Total Payments
$16,380
2024 Payments
$4,167
Companies
70
Transactions
907
Medicare Patients
16,242
Medicare Billing
$3.2M
Payment Breakdown by Category
Food & Beverage$16,171 (98.7%)
Other$189.12 (1.2%)
Education$20.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,171 | 893 | 98.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $189.12 | 13 | 1.2% |
| Education | $20.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,992 | 104 | $0 (2024) |
| Biogen, Inc. | $1,645 | 123 | $0 (2024) |
| PFIZER INC. | $736.61 | 50 | $0 (2024) |
| EMD Serono, Inc. | $673.20 | 37 | $0 (2024) |
| Amgen Inc. | $647.37 | 31 | $0 (2024) |
| Grifols USA, LLC | $646.41 | 33 | $0 (2024) |
| Alexion Pharmaceuticals, Inc. | $573.88 | 30 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $539.53 | 19 | $0 (2024) |
| Lundbeck LLC | $492.16 | 40 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $468.27 | 24 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,167 | 222 | ABBVIE INC. ($454.38) |
| 2023 | $3,191 | 185 | ABBVIE INC. ($553.59) |
| 2022 | $2,882 | 151 | ABBVIE INC. ($399.63) |
| 2021 | $1,862 | 109 | AbbVie Inc. ($424.78) |
| 2020 | $368.88 | 22 | Biogen, Inc. ($63.17) |
| 2019 | $1,517 | 90 | EMD Serono, Inc. ($192.66) |
| 2018 | $1,184 | 68 | GENZYME CORPORATION ($127.76) |
| 2017 | $1,208 | 60 | Biogen, Inc. ($155.82) |
All Payment Transactions
907 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.92 | General |
| 12/18/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Grifols USA, LLC | Gamunex-C (Biological) | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Immunology and Neurology | ||||||
| 12/16/2024 | SCILEX PHARMACEUTICALS INC. | ELYXYB - CELECOXIB (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Pain Management | ||||||
| 12/13/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $0.45 | General |
| Category: Neurology | ||||||
| 12/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $23.78 | General |
| Category: Rare Disease | ||||||
| 12/11/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/09/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $30.83 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $29.96 | General |
| Category: Immunology | ||||||
| 12/04/2024 | PFIZER INC. | OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug), PANZYGA | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $1.23 | General |
| Category: Immunology | ||||||
| 11/26/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $0.59 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/25/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $35.93 | General |
| Category: Neuropsychiatry | ||||||
| 11/21/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $22.00 | General |
| 11/20/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $0.44 | General |
| 11/19/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $35.24 | General |
| Category: Immunology | ||||||
| 11/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: PSYCHIATRY | ||||||
| 11/16/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $25.58 | General |
| 11/15/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $23.36 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | HYQVIA (Biological) | Food and Beverage | In-kind items and services | $34.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Analgesic | ||||||
| 11/14/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: BOTOX THERAPEUTIC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 4,732 | 5,222 | $1.2M | $886,951 |
| 2022 | 22 | 4,297 | 4,763 | $1.1M | $858,316 |
| 2021 | 19 | 4,097 | 4,492 | $1.1M | $832,471 |
| 2020 | 15 | 3,116 | 3,373 | $797,897 | $605,963 |
Total Patients
16,242
Total Services
17,850
Medicare Billing
$3.2M
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2023 | 776 | 822 | $272,088 | $218,176 | 80.2% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2023 | 777 | 823 | $265,586 | $211,984 | 79.8% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2023 | 776 | 822 | $161,467 | $129,240 | 80.0% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 748 | 793 | $182,534 | $116,105 | 63.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 402 | 658 | $96,799 | $71,757 | 74.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 268 | 268 | $52,201 | $38,109 | 73.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 470 | 470 | $44,415 | $34,185 | 77.0% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 129 | 160 | $17,725 | $14,203 | 80.1% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 70 | 70 | $17,047 | $13,189 | 77.4% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 46 | 46 | $15,107 | $11,892 | 78.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 50 | 50 | $7,441 | $5,971 | 80.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 60 | 71 | $6,384 | $5,122 | 80.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 31 | $6,467 | $4,996 | 77.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 37 | $3,859 | $3,096 | 80.2% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 23 | 26 | $3,751 | $3,010 | 80.2% |
| 95912 | Nerve conduction, 11-12 studies | Office | 2023 | 13 | 13 | $3,704 | $2,656 | 71.7% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 11 | 11 | $2,237 | $1,632 | 72.9% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 24 | 27 | $1,102 | $851.50 | 77.2% |
| 96139 | Administration of psychological or neuropsychological test by technician, each additional 30 minutes | Office | 2023 | 21 | 24 | $1,009 | $778.68 | 77.2% |
| 93890 | Ultrasound of within the brain blood flow following medication | Office | 2022 | 697 | 744 | $258,770 | $207,579 | 80.2% |
| 93886 | Complete ultrasound of within the brain blood flow | Office | 2022 | 697 | 744 | $255,669 | $204,111 | 79.8% |
| 93892 | Ultrasound of within the brain blood flow for blood clots | Office | 2022 | 696 | 743 | $154,611 | $123,798 | 80.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2022 | 687 | 733 | $180,324 | $113,001 | 62.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 289 | 502 | $76,992 | $56,589 | 73.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 378 | 378 | $38,177 | $29,077 | 76.2% |
About Dr. Michael Han, M.D
Dr. Michael Han, M.D is a Specialist healthcare provider based in New Hyde Park, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2009. The National Provider Identifier (NPI) number assigned to this provider is 1346489689.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Han, M.D has received a total of $16,380 in payments from pharmaceutical and medical device companies, with $4,167 received in 2024. These payments were reported across 907 transactions from 70 companies. The most common payment nature is "Food and Beverage" ($16,171).
As a Medicare-enrolled provider, Han has provided services to 16,242 Medicare beneficiaries, totaling 17,850 services with total Medicare billing of $3.2M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location New Hyde Park, NY
- Active Since 02/10/2009
- Last Updated 02/10/2009
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1346489689
Products in Payments
- TYSABRI (Biological) $1,236
- UBRELVY (Drug) $849.12
- QULIPTA (Drug) $727.74
- Gamunex-C (Biological) $646.41
- VYEPTI (Biological) $416.94
- NURTEC ODT (Drug) $416.85
- Aimovig (Biological) $396.61
- HYQVIA (Biological) $334.33
- Leqembi (Drug) $321.44
- PANZYGA (Biological) $317.74
- AUBAGIO (Drug) $313.63
- INGREZZA (Drug) $313.09
- UPLIZNA (Drug) $277.60
- NUPLAZID (Drug) $276.22
- ACTHAR (Biological) $263.27
- OCTAGAM IMMUNE GLOBULIN (HUMAN) (Drug) $254.80
- BOTOX (Biological) $249.44
- Nourianz (Drug) $244.90
- AJOVY (Biological) $243.22
- ULTOMIRIS (Biological) $236.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in New Hyde Park
Dr. Elliott Salamon, Do, DO
Specialist — Payments: $52,956
Specialist $52,956
Dr. Andrew Porges, Md, MD
Specialist — Payments: $30,781
Specialist $30,781
Dr. Ivan Pavkovic, M.d, M.D
Specialist — Payments: $29,318
Specialist $29,318
Dr. Joseph Ramek, M.d, M.D
Specialist — Payments: $26,475
Specialist $26,475
Dr. Slavina Gardella, M.d, M.D
Specialist — Payments: $23,827
Specialist $23,827
Victor Katz, Md, MD
Specialist — Payments: $19,161
Specialist $19,161